Dott.ssa Valeria Tomarchio
Biography
Valeria Tomarchio born in Catania on 28/11/1984:
- July 2003; Scientific High School Diploma with a grade of 100/100 from the State Scientific High School or “Leonardo Da Vinci” in Giarre (CT)
- July 2009; Master's Degree in Medicine and Surgery from the Campus Biomedico University of Rome, with a grade of 110/110 cum laude. Thesis defense entitled "Treatment of Non-Hodgkin's Lymphomas in the Rituximab Era: Experience at the Campus Biomedico University of Rome," Supervisor: Prof. Giuseppe Avvisati.
- February 2010; License to practice and registration in the professional register of Surgeons of Catania, Order of Surgeons and Dentists of the Province of Catania
- May 2015; Diploma as a Specialist in Hematology with a grade of 50/50 and honors. At Università Campus Bio-Medico di Roma, Thesis entitled “Retrospective study of patients affected by blastic plasmacytoid dendritic cell neoplasia: evaluation of clinical, diagnostic, therapeutic characteristics and outcome” Supervisor Prof. Giuseppe Avvisati.
- June 2015; Private hematologist at the Hematology and Stem Cell Transplant Unit of the “Policlinico Universitario Campus Bio-Medico”
- June 2018 to date; Hematologist with a permanent contract at the Hematology and Stem Cell Transplant Unit of the "Policlinico Universitario Campus Bio-Medico"
Curriculum
October 2005 – June 2006 Elective Internship at the “Microscopic Anatomy Laboratories and Microscopic Anatomy Activities” Supervisor Prof. Sergio Morini.
September 2009 Observer Physician at Vancouver General Hospital: Observer physician activity in the Hematology and Leukemia/Bone Marrow Transplantation Day-Care division of Vancouver General Hospital. Supervisor: Prof. M Barnett.
May 2010 - May 2015 Resident in “Hematology”, under the supervision of Prof. G. Avvisati, at the “Policlinico Universitario Campus Bio-Medico”, Rome
Activities
- Gradual management of patients with hematological malignancies and non-neoplastic hematological diseases, including diagnostics, therapy, and follow-up; activities carried out in the Hematology, Stem Cell Transplant, and Cellular Therapy Unit of the "Policlinico Universitario Campus Bio-Medico";
- Participation in the management of experimental chemotherapy protocols of cooperative groups such as Internal Data Monitor: GIMEMA; Fondazione Italiana Linfomi (FIL), International Extranodal Lymphoma Group (IELSG), European Myeloma Network (EMN);
October 2014–March 2015: Visiting physician and researcher at City of Hope Medical Center, Duarte, Los Angeles, California. Supervisor: Professor Amrita Krishnan.
Activities
- Evaluation as an “observer” of patients affected by hematological malignancies in the context of diagnostics, therapy and follow-up and in particular in the setting of autologous and allogeneic hematopoietic stem cell transplantation;
- Laboratory research activity focused on the study of the role of glucose and its transport receptors within tumor cells, particularly in patients with multiple myeloma and non-Hodgkin's lymphoma, in order to evaluate the biochemical, cellular, and molecular pathways involved in the development of chemoresistance and to study them as therapeutic targets.
- Research activity related to the management of the rare hematological disease Plasmacytoid Dendritic Blast Cell Neoplasia
- Participation in the drafting of an experimental chemotherapy protocol: “Phase I/II Clinical Trial of the Combination of Oral Metformin and Ritonavir in Patients with Relapsed/Refractory Hematological Malignancies”
March 2016-February 2017
Advanced Training Course in Statistical Methods for Biomedical Research and Practice at the University of Rome "La Sapienza" Prof. P. Villari
From June 2018 to now, hematologist with a permanent contract at the UOC of Hematology and Stem Cell Transplant of the “Policlinico Universitario Campus Bio-Medico.
Activities
- Management of patients with hematological malignancies and non-neoplastic hematological diseases, their treatment, and follow-up. Management of patients undergoing autologous hematopoietic stem cell transplantation and related complications. Activities carried out at the Hematology, Stem Cell Transplant, and Cellular Therapy Unit of the "Policlinico Universitario Campus Bio-Medico";
- Providing haematological consultation services in the university hospital departments;
- Participation in the management of experimental chemotherapy protocols of the cooperative groups: GIMEMA; Fondazione Italiana Linfomi (FIL), International Extranodal Lymphoma Group (IELSG), European Myeloma Network (EMN);
- Carrying out interdivisional guard duties at the university hospital and the CESA (senior citizen center)
Since 2022 teaching activity (1 CFU) (subject: Clinical Medicine 2) at the Campus Biomedico University of Rome, Faculty of Medicine and Surgery
PUBLICATIONS
-Scarlata, S., Annibali, O., Santangelo, S., Tomarchio, V., Ferraro, S., Armiento, D., ... & Avvisati, G. (2017). Pulmonary complications and survival after autologous stem cell transplantation: predictive role of pulmonary function and pneumotoxic medications. European Respiratory Journal, 49(3), 1601902.
-Annibali O, Fabbriciani G, Tafuri M, Massarotti M, Sedati P, Tomarchio V, Elena S, Stefano P, Selmi C, Avvisati G. Primary bone lymphoma of the talus: a challenging diagnosis. Tumori. 2017 Aug 28:0.
-Annibali O., Pensieri C., Tomarchio V,, Biagioli V., Pennacchini M.,, Tendas A., Tambone V., Tirindelli MC, Protective Isolation for Patients with Haematological Malignancies: A Pilot Study Investigating Patients' Distress and Use of Time. International Journal of Hematology-Oncology and Stem Cell Research
-Annibali, O., Crescenzi, A., Tomarchio, V., Pagano, A., Bianchi, A., Grifoni, A., & Avvisati, G. (2018). PD-1/PD-L1 checkpoint in hematological malignancies. Leukemia research.
- Tendas, A., Marchesi, F., Mengarelli, A., Annibali, O., Tomarchio, V., Saltarelli, D., ... & Arcese, W. (2019). Prevention of chemotherapy-induced nausea and vomiting after high-dose melphalan and stem cell transplantation: review of the evidence and suggestions. Supportive Care in Cancer, 27(3), 793-803.
- Gini, G., Annibali, O., Lupasco, D., Bocci, C., Tomarchio, V., Sampaolo, M., ... & Olivieri, A. (2019). Gonadal function recovery and fertility in women treated with chemo-and/or radiotherapy for Hodgkin's and Non-Hodgkin lymphoma. Chemotherapy, 64(1), 36-41.
- Annibali, O., Hohaus, S., Marchesi, F., Cantonetti, M., Di Rocco, A., Tomarchio, V., ... & Cox, M.C. (2019). The neutrophil/lymphocyte ratio ≥ 3.5 is a prognostic marker in diffuse large B-cell lymphoma: a retrospective analysis from the database of the Italian regional network 'Rete Ematologica del Lazio per i Linfomi' (RELLI). Leukemia & lymphoma, 60(14), 3386-3394.
-Nathwani, N., Palmer, J., Synold, T.W., Salehian, B., Rosenzweig, M., Sanchez, J.F. Tomarchio V, ... & Rosen, S.T. (2020). Toxicities Associated With Metformin/Ritonavir Combination Treatment in Relapsed/Refractory Multiple Myeloma. Clinical Lymphoma, Myeloma and Leukemia, 20(10), e667-e672.
- Annibali, O., Bianchi, A., Grifoni, A., Tomarchio, V., Tafuri, M., Verri, M., ... & Crescenzi, A. (2021). A novel scoring system for TIGIT expression in classic Hodgkin lymphoma. Scientific Reports, 11(1), 1-8.
- Rinaldi, F., Marchesi, F., Palombi, F., Pelosi, A., Di Pace, AL, Sacconi, A., Tomarchio V ... & Rizzo, MG (2021). MiR‐22, a serum predictor of poor outcome and therapy response in diffuse large B‐cell lymphoma patients. British Journal of Haematology.
- Fazio, F., Franceschini, L., Tomarchio, V., Rago, A., Garzia, MG, Cupelli, L., ... & Petrucci, MT (2022). Daratumumab combined with dexamethasone and lenalidomide or bortezomib in relapsed/refractory multiple myeloma (RRMM) patients: Report from the multiple myeloma GIMEMA Lazio group. EJHaem, 3(1), 121-128.
- Rago, A., Annibali, O., Tomarchio, V., Coppetelli, U., Fazio, F., Cupelli, L., ... & Caravita di Toritto, T. (2022). Autologous stem cell transplantation in multiple myeloma patients over 70 years: A GIMEMA Lazio Working Group experience in a retrospective case–control study. European Journal of Haematology, 109(3), 250-256.
- Annibali, O., Tomarchio, V., Gregorj, C., Di Cerbo, M., Armiento, D., Antonelli, L., ... & Avvisati, G. (2023). Circulating endothelial cell (CEC) kinetics in patients with Multiple Myeloma (MM) who receive Au-HSCT (Autologous Hematopoietic Stem Cell Transplantation). Chemotherapy.